Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study

Congenital extrahepatic portosystemic shunt (CEPS) or Abernethy malformation is a rare condition in which splanchnic venous blood bypasses the liver draining directly into systemic circulation through a congenital shunt. Patients may develop hepatic encephalopathy (HE), pulmonary hypertension (PaHT), or liver tumors, among other complications. However, the actual incidence of such complications is unknown, mainly because of the lack of a protocolized approach to these patients. This study characterizes the clinical manifestations and outcome of a large cohort of CEPS patients with the aim of proposing a guide for their management. This is an observational, multicenter, international study. Sixty‐six patients were included; median age at the end of follow‐up was 30 years. Nineteen patients (28%) presented HE. Ten‐, 20‐, and 30‐year HE incidence rates were 13%, 24%, and 28%, respectively. No clinical factors predicted HE. Twenty‐five patients had benign nodular lesions. Ten patients developed adenomas (median age, 18 years), and another 8 developed HCC (median age, 39 years). Of 10 patients with dyspnea, PaHT was diagnosed in 8 and hepatopulmonary syndrome in 2. Pulmonary complications were only screened for in 19 asymptomatic patients, and PaHT was identified in 2. Six patients underwent liver transplantation for hepatocellular carcinoma or adenoma. Shunt closure was performed in 15 patients with improvement/stability/cure of CEPS manifestations. Conclusion: CEPS patients may develop severe complications. Screening for asymptomatic complications and close surveillance is needed. Shunt closure should be considered both as a therapeutic and prophylactic approach.

[1]  D. Pariente,et al.  Congenital portosystemic shunts: diagnosis and treatment , 2018, Abdominal Radiology.

[2]  F. Gottrand,et al.  Outcome of intrahepatic portosystemic shunt diagnosed prenatally , 2017, European Journal of Pediatrics.

[3]  P. Amodio,et al.  Cognitive reserve is a resilience factor for cognitive dysfunction in hepatic encephalopathy , 2017, Metabolic Brain Disease.

[4]  Richard J. Thompson,et al.  Case Report: Multiple beta-catenin mutations in hepatocellular lesions arising in Abernethy Malformation , 2016 .

[5]  M. Rodriguez-Davalos,et al.  Congenital Extrahepatic Portosystemic Shunt (Abernethy Malformation Type Ib) With Associated Hepatocellular Carcinoma , 2016, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[6]  H. Yiğit,et al.  Multiple regenerative nodular hyperplasia in the left infrarenal vena cava accompanied by abernethy malformation , 2016, Surgical and Radiologic Anatomy.

[7]  Ying Guo,et al.  Congenital extrahepatic portosystemic shunt: an underdiagnosed but treatable cause of hepatopulmonary syndrome , 2016, European Journal of Pediatrics.

[8]  J. Encinas,et al.  Congenital Portosystemic Shunts: Clinic Heterogeneity Requires an Individual Management of the Patient , 2015, European Journal of Pediatric Surgery.

[9]  N. Heaton,et al.  Congenital extrahepatic portosystemic shunt complicated by the development of hepatocellular carcinoma. , 2015, Hepatobiliary & pancreatic diseases international : HBPD INT.

[10]  Lucas Nacif,et al.  Significance of CT scan and color Doppler duplex ultrasound in the assessment of Abernethy malformation , 2015, BMC Medical Imaging.

[11]  Zhongwei Qiao,et al.  Congenital portosystemic shunts with and without gastrointestinal bleeding – case series , 2015, Pediatric Radiology.

[12]  J. Bueno,et al.  [Congenital portosistemic shunt. Importance of early treatment]. , 2015, Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica.

[13]  M. Kasahara,et al.  The classification based on intrahepatic portal system for congenital portosystemic shunts. , 2015, Journal of pediatric surgery.

[14]  D. Pariente,et al.  Congenital Portosystemic Shunts in Children: A New Anatomical Classification Correlated With Surgical Strategy , 2014, Annals of surgery.

[15]  H. Youn,et al.  A Case of Pulmonary Arterial Hypertension Associated with Congenital Extrahepatic Portocaval Shunt , 2014, Journal of Korean medical science.

[16]  C. Sokollik,et al.  Congenital Portosystemic Shunt: Characterization of a Multisystem Disease , 2013, Journal of pediatric gastroenterology and nutrition.

[17]  T. Blanc,et al.  Congenital portosystemic vascular malformations. , 2012, Seminars in pediatric surgery.

[18]  J. Ijzermans,et al.  Management strategy after diagnosis of Abernethy malformation: a case report , 2012, Journal of Medical Case Reports.

[19]  S. Digumarthy,et al.  Congenital portosystemic shunts: imaging findings and clinical presentations in 11 patients. , 2011, European journal of radiology.

[20]  R. Superina,et al.  Management and classification of type II congenital portosystemic shunts. , 2011, Journal of pediatric surgery.

[21]  J. Riou,et al.  Complications of Congenital Portosystemic Shunts in Children: Therapeutic Options and Outcomes , 2010, Journal of pediatric gastroenterology and nutrition.

[22]  Marc Gewillig,et al.  Congenital veno‐venous malformations of the liver: Widely variable clinical presentations , 2008, Journal of gastroenterology and hepatology.

[23]  K. Ihara,et al.  Pulmonary Hypertension in Patients With Congenital Portosystemic Venous Shunt: A Previously Unrecognized Association , 2008, Pediatrics.

[24]  M. Stringer,et al.  The clinical anatomy of congenital portosystemic venous shunts , 2008, Clinical anatomy.

[25]  N. Kawashima,et al.  Resolution of hepatopulmonary syndrome after ligation of a portosystemic shunt in a pediatric patient with an Abernethy malformation. , 2008, Journal of pediatric surgery.

[26]  Michael Karin,et al.  References and Notes Supporting Online Material Materials and Methods Som Text Figs. S1 to S6 Tables S1 to S4 Gender Disparity in Liver Cancer Due to Sex Differences in Myd88-dependent Il-6 Production , 2022 .

[27]  Paul S. Babyn,et al.  Congenital extrahepatic portosystemic shunts , 2003, Pediatric Radiology.

[28]  S. Matsumoto,et al.  Congenital extrahepatic portocaval shunt associated with hepatic hyperplastic nodules in a patient with Dubin–Johnson syndrome , 2000, Abdominal Imaging.

[29]  K. Sugimachi,et al.  Portal-systemic encephalopathy due to a congenital extrahepatic portosystemic shunt: three cases and literature review. , 2000, Hepato-gastroenterology.

[30]  F. Endo,et al.  The long-term prognosis of congenital portosystemic venous shunt. , 1999, The Journal of pediatrics.

[31]  F. Endo,et al.  Surgical indications for patients with hyperammonemia. , 1999, Journal of pediatric surgery.

[32]  N. Sakura,et al.  Clinical features and outcome of eight infants with intrahepatic porto‐venous shunts detected in neonatal screening for galactosaemia , 1998, Acta paediatrica.

[33]  R. Gitzelmann,et al.  Hypergalactosaemia in a newborn: self-limiting intrahepatic portosystemic venous shunt , 1997, European Journal of Pediatrics.

[34]  E R Howard,et al.  Congenital extrahepatic portocaval shunts--the Abernethy malformation. , 1997, Journal of pediatric surgery.

[35]  G. Morgan,et al.  Congenital absence of the portal vein: two cases and a proposed classification system for portasystemic vascular anomalies. , 1994, Journal of pediatric surgery.

[36]  S. Futterman,et al.  Benign Liver Cell Adenoma Associated With Use of Oral Contraceptive Agents , 1976, Annals of surgery.